Using AutoDeck Vina to Create a Quercetin Derivative for Binding Xanthine Oxidase

Abstract

Quercetin is an anti-hyperuricemia agent that competitively inhibits the natural ligands for binding at the active site of Xanthine Oxidase (XOD), which catalyzes the oxidation of hypoxanthine to xanthine and then to urate. It is an old treatment for gout, a disease resulting from the buildup of uric acid crystals in the joints of limbs. The purpose of this study is to find a water soluble quercetin derivative with higher affinity for the XOD active site.